Skip to main content

Table 4 Pharmacists’ perceived extent of involvement in general patient care and palliative care services

From: Pharmacists’ knowledge, attitude and involvement in palliative care in selected tertiary hospitals in southwestern Nigeria

My involvement in patient care as a pharmacist entails:Not at all
n (%)
Rarely
n (%)
Occasionally n (%)Frequently n (%)
1.Explain misconceptions about addictive medication (n = 110)7 (6.4)18 (16.4)37 (33.6)48 (43.6)
2. Visit patients’ homes to communicate directly with patients and their caregivers and to make necessary assessments (n = 110)60 (54.5)36 (32.7)11 (10.0)3 (2.7)
3. Monitor patients’ medication profile for safety and effectiveness (n = 109)2 (1.8)31 (28.4)33 (30.3)43 (39.4)
4. Provide patients with essential medications that ensure continuous symptom control (n = 110)14 (12.7)6 (5.5)15 (13.6)75 (68.2)
5. Attend clinical meetings to advise other members of healthcare team about medication therapy (n = 110)12 (10.9)22 (20.0)45 (40.9)31 (28.2)
6. Advise clinical team on dosage forms and adjustments, routes of administration, costs, and availability of various drug products (n = 110)15 (13.6)13 (11.8)42 (38.2)40 (36.4)
7. Give educational sessions (n = 110)15 (13.6)23 (20.9)47 (42.7)25 (22.7)
8. Advise members of the clinical team about the potential for toxicity and interactions with dietary supplements and alternative therapies (n = 110)13 (11.8)34 (30.9)37 (33.6)26 (23.6)
9. Ensure that all medication labeling is complete and understandable by patients and their caregivers (n = 110)4 (3.6)4 (3.6)2 (1.8)100 (90.9)
10. Communicate with patients about the importance of adhering to the prescribed drug regimen (n = 110)0 (0.0)4 (3.6)6 (5.5)100 (90.9)
11. Monitor all prescription and nonprescription medication use (n = 108)3 (2.8)7 (6.5)38 (35.2)60 (55.5)
12. Counsel patients about potential toxicity of alternative and complementary therapies (n = 109)2 (1.8)9 (8.3)35 (32.1)63 (57.8)
13. Extemporaneous preparation of non-conventional dosage forms for ease of administration to patients (n = 109)4 (3.7)5 (4.6)28 (25.7)72 (66.1)
14. Prepare flavouring medications to promote compliance (n = 103)5 (4.9)16 (15.5)40 (38.8)42 (40.8)
15. Address issues on cost of patients’ medications (n = 110)6 (5.5)12 (10.9)43 (39.1)49 (44.5)
16. Ensure that drug disposal is in compliance with federal and state drug control and environmental protection laws and regulations (n = 103)3 (2.9)16 (15.5)26 (25.2)58 (56.3)
  1. n Number